Cubosomes are highly stable nanoparticles formed from the lipid cubic phase and stabilized
by a polymer based outer corona. Bicontinuous lipid cubic phases consist of a single lipid …

Lipid-based drug-delivery nanoparticles, including non-lamellar-type, mesophasic
nanostructured materials of lyotropic liquid crystals (LLCs), have been a topic of interest for …

Nonlamellar lyotropic liquid crystalline (LLC) lipid nanomaterials have emerged as a
promising class of advanced materials for the next generation of nanomedicine, comprising …

Amphiphilic lipids aggregate in aqueous solution into a variety of structural arrangements.
Among the plethora of ordered structures that have been reported, many have also been …

Liquid crystals (LCs) possess unique physicochemical properties, translatable into a wide
range of applications. To date, lipidic lyotropic LCs (LLCs) have been extensively explored …

The sheet‐like lipid bilayer is the fundamental structural component of all cell membranes.
Its building blocks are phospholipids and cholesterol. Their amphiphilic structure …

The use of lipid nanocarriers for drug delivery applications is an active research area, and a
great interest has particularly been shown in the past two decades. Among different lipid …

Liquid crystal (LC)-based nanoformulations may efficiently deliver drugs and therapeutics to
targeted biological sites. Lyotropic liquid crystalline phases (LLCPs) have received much …

Nanomedicines, while having been approved for cancer therapy, present many challenges
such as low stability, rapid clearance, and nonspecificity leading to off-target toxicity …

Implant-associated infections (IAIs) represent a major health burden due to the complex
structural features of biofilms and their inherent tolerance to antimicrobial agents and the …